RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.
about
Dissecting the role of bone marrow stromal cells on bone metastases.RANKL: A promising circulating marker for bone metastasis responseThe role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton.Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL.The inhibition of RANKL-induced osteoclastogenesis through the suppression of p38 signaling pathway by naringenin and attenuation of titanium-particle-induced osteolysis.
P2860
RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
RANK/RANK-L/OPG in patients wi ...... nic acid: a prospective study.
@en
RANK/RANK-L/OPG in patients wi ...... nic acid: a prospective study.
@nl
type
label
RANK/RANK-L/OPG in patients wi ...... nic acid: a prospective study.
@en
RANK/RANK-L/OPG in patients wi ...... nic acid: a prospective study.
@nl
prefLabel
RANK/RANK-L/OPG in patients wi ...... nic acid: a prospective study.
@en
RANK/RANK-L/OPG in patients wi ...... nic acid: a prospective study.
@nl
P2093
P2860
P50
P356
P1476
RANK/RANK-L/OPG in patients wi ...... nic acid: a prospective study.
@en
P2093
Dino Amadori
Erica Gunelli
Francesca Fabbri
Marianna Ricci
Patrizia Serra
Roberta Maltoni
Rossana Ricci
Wainer Zoli
P2860
P304
10683-10693
P356
10.3390/IJMS140610683
P407
P577
2013-05-23T00:00:00Z